These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35957159)

  • 1.
    Karageorgou MA; Rapsomanikis AN; Mirković M; Vranješ-Ðurić S; Stiliaris E; Bouziotis P; Stamopoulos D
    Nanomaterials (Basel); 2022 Aug; 12(15):. PubMed ID: 35957159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-Camera Direct Imaging of the Plasma and On/Intra Cellular Distribution of the
    Karageorgou MA; Apostolopoulou A; Tomazinaki ME; Stanković D; Stiliaris E; Bouziotis P; Stamopoulos D
    Materials (Basel); 2024 Jan; 17(2):. PubMed ID: 38255503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemocompatibility of gallium-68 labeled iron oxide nanoparticles coated with 2,3-dicarboxypropane-1,1-diphosphonic acid.
    Karageorgou MA; Bouziotis P; Vranješ-Djurić S; Stamopoulos D
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111121. PubMed ID: 32600720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis.
    Tsoukalas C; Psimadas D; Kastis GA; Koutoulidis V; Harris AL; Paravatou-Petsotas M; Karageorgou M; Furenlid LR; Moulopoulos LA; Stamopoulos D; Bouziotis P
    Front Chem; 2018; 6():224. PubMed ID: 29974048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One pot synthesis of zwitteronic 99mTc doped ultrasmall iron oxide nanoparticles for SPECT/T1-weighted MR dual-modality tumor imaging.
    Wang P; Sun W; Guo J; Zhang K; Liu Y; Jiang Q; Su D; Sun X
    Colloids Surf B Biointerfaces; 2021 Jan; 197():111403. PubMed ID: 33099146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study.
    Karageorgou MA; Vranješ-Djurić S; Radović M; Lyberopoulou A; Antić B; Rouchota M; Gazouli M; Loudos G; Xanthopoulos S; Sideratou Z; Stamopoulos D; Bouziotis P; Tsoukalas C
    Contrast Media Mol Imaging; 2017; 2017():6951240. PubMed ID: 29445321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles.
    Karageorgou MA; Stamopoulos D
    Sci Rep; 2021 May; 11(1):9753. PubMed ID: 33963211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of ανβ3-mediated tumor expression and feasibility for hyperthermia treatment.
    Tsiapa I; Efthimiadou EK; Fragogeorgi E; Loudos G; Varvarigou AD; Bouziotis P; Kordas GC; Mihailidis D; Nikiforidis GC; Xanthopoulos S; Psimadas D; Paravatou-Petsotas M; Palamaris L; Hazle JD; Kagadis GC
    J Colloid Interface Sci; 2014 Nov; 433():163-175. PubMed ID: 25128864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (99m)Tc radiolabelling of Fe3O4-Au core-shell and Au-Fe3O4 dumbbell-like nanoparticles.
    Felber M; Alberto R
    Nanoscale; 2015 Apr; 7(15):6653-60. PubMed ID: 25797603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI.
    Karageorgou MA; Bouziotis P; Stiliaris E; Stamopoulos D
    Nanomaterials (Basel); 2023 Jan; 13(3):. PubMed ID: 36770463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (⁹⁹m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging.
    Torres Martin de Rosales R; Tavaré R; Glaria A; Varma G; Protti A; Blower PJ
    Bioconjug Chem; 2011 Mar; 22(3):455-65. PubMed ID: 21338098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeling and Preliminary Evaluation of
    Duan X; Du Y; Wang C; Zhao Z; Li C; Li J
    Int J Nanomedicine; 2021; 16():5665-5673. PubMed ID: 34447248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, radiolabeling with
    de Arcocha-Torres M; Quincoces G; Martínez-López AL; Erhard A; Collantes M; Martínez-Rodríguez I; Ecay M; Banzo I; Irache JM; Peñuelas I
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):225-232. PubMed ID: 32201272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinically translatable kit for MRI/NMI dual-modality nanoprobes based on anchoring group-mediated radiolabeling.
    Chen L; Gao Y; Ge J; Zhou Y; Yang Z; Li C; Huang B; Lu K; Kou D; Zhou D; Chen C; Wang S; Wu S; Zeng J; Huang G; Gao M
    Nanoscale; 2023 Feb; 15(8):3991-3999. PubMed ID: 36723217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging.
    Adamiano A; Iafisco M; Sandri M; Basini M; Arosio P; Canu T; Sitia G; Esposito A; Iannotti V; Ausanio G; Fragogeorgi E; Rouchota M; Loudos G; Lascialfari A; Tampieri A
    Acta Biomater; 2018 Jun; 73():458-469. PubMed ID: 29689381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of Tc-99m and fluorescence-labeled elastin-derived peptide, VAPG for multimodal tumor imaging in murine tumor model.
    Kim MH; Kim CG; Kim SG; Kim DW
    J Labelled Comp Radiopharm; 2017 Dec; 60(14):649-658. PubMed ID: 29023950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel dual-labeled small peptide as a multimodal imaging agent for targeting wild-type EGFR in tumors.
    Kim MH; Kim SG; Kim DW
    PLoS One; 2022; 17(2):e0263474. PubMed ID: 35120180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel Tc-99m and fluorescence-labeled arginine-arginine-leucine-containing peptide as a multimodal tumor imaging agent in a murine tumor model.
    Kim MH; Kim SG; Kim DW
    J Labelled Comp Radiopharm; 2018 Jun; 61(7):557-566. PubMed ID: 29603784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes.
    Madru R; Kjellman P; Olsson F; Wingårdh K; Ingvar C; Ståhlberg F; Olsrud J; Lätt J; Fredriksson S; Knutsson L; Strand SE
    J Nucl Med; 2012 Mar; 53(3):459-63. PubMed ID: 22323777
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.